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ABSTRACT 
Knowledge, Attitudes and Practices of Healthcare Providers towards Prenatal HIV 
Screening and Prevention of Mother-To-Child Transmission in Nigeria 
L. Nneka Mobisson. Yale University School of Medicine. Department of Obstetrics & 
Gynecology. New Haven, Connecticut 
The purpose of this study was to assess the knowledge, attitudes and practices of 
healthcare providers regarding prenatal HIV screening and the use of antiretroviral drugs 
in the prevention of mother-to-child transmission of HIV in Nigerian pregnant women. A 
cross-sectional survey using self-administered questionnaires among 150 healthcare 
providers (physicians and nurses) was conducted at four healthcare facilities in Nigeria 
from June to August 2000. Two of these healthcare facilities are the designated pilot 
centers for the national prevention of mother-to-child-transmission (PMTCT) program. 
Differences in responses between physicians and nurses were compared for each 
category. Of 150 self-administered questionnaires that were fielded, 86 healthcare 
providers responded, for a response rate of 57%. Less than two-thirds of respondents had 
correct knowledge regarding the use of antiretroviral drugs in mother-to-child 
transmission with physicians being more knowledgeable than nurses. Despite the 
differences in knowledge levels, more nurses than physicians agreed on the importance of 
screening pregnant women for HIV (93% vs. 70.91%; P=0.04). In addition, a 
significantly larger proportion of nurses routinely inquire about the HIV status of 
pregnant women (60% vs. 38%). Current healthcare providers have limited knowledge 
levels regarding the use of antiretroviral drugs in the prevention of mother-to-child 
transmission. In addition, a significant proportion of healthcare providers do not have 
attitudes or practices conducive to the prevention of perinatal transmission. This may 
negatively impact on the success of the PMTCT programs in Nigeria. This study 
highlights the need for continuous and comprehensive training of healthcare providers at 
government and private healthcare facilities to increase the likelihood of achieving the 
objectives of PMTCT programs. 
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INTRODUCTION 
A. The HIV/AIDS Burden in Nigeria 
Each year, an estimated 700,000 children around the world contract the HIV vims, 
mostly through perinatal transmission. (1) The Sub-Saharan African region has the 
largest proportion of these new infections. In the western world, such infections have 
been reduced to a large extent by institution of antiretroviral regimens, elective cesarean 
sections, and exclusive formula feeding. However, the institution of such programs in 
developing countries has been extremely challenging due to the high cost and resource 
requirements of such interventions. 
In Sub-Saharan Africa, the countries hardest hit by the epidemic have been the 
southern African countries such as South Africa, Botswana, and Zimbabwe where 
prevalence rates range from 20.1% (2) to 38.8% (3). Equally alarming, however, is the 
HIV/AIDS situation in West African countries such as Nigeria. There are an estimated 
3.5 million Nigerians living with HIV/AIDS and it currently has the third largest number 
of HIV-positive people in the world (4). The prevalence of HIV in Nigeria, although 
remaining comparatively low, has steadily increased over the last decade. According to 
the Nigerian Federal Ministry of Health Sentinel sero-sentinel surveys, the prevalence of 
HIV in Nigeria has risen from 1.8% in 1991 to 5.8% in 2001 (5,6). This prevalence rate is 
projected to increase to 15% by 2010 (7) (Figure 1). 
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FIGURE 1. Nigeria’s HIV Prevalence. Nigerian Federal Ministry of Health. 2001. 
The overall percentage of HIV-positive people in Nigeria may appear small in 
comparison with other Sub-Saharan countries like South Africa and Botswana. However, 
Nigeria is the most populous country in sub-Saharan Africa with over 123 million 
residents. As such, the absolute number of HIV-infected Nigerians is high. 
B. Prevalence of HIV in pregnant women and children 
The median prevalence of HIV disease in urban and rural antenatal clinics increased from 
1% in 1991 to 5% in 1999 (8). As of 2001, prevalence rates at antenatal clinics were as 
high as 10% in some states in Nigeria (9). Numbers currently do not exist for the 
estimated percent of Nigerian HIV-positive pregnant women because of the lack of 
routine voluntary counseling and testing. However, it is estimated that one out of eight 
pregnant women is HIV-positive (10). With an average fertility rate of 6 births per 
Nigerian woman (11), the number of HIV cases resulting from perinatal transmission is 
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expected to increase significantly. According to UNICEF, an estimated 4.7 million 
pregnancies occur in Nigeria every year and, with an estimated 45% perinatal 
transmission rate (12), approximately 220,000 HIV-positive children will be born each 
year. As of 2002, there were an estimated 750,000 children who were HIV-positive (13). 
Since HIV/AIDS is largely spread by heterosexual transmission, it is likely that the 
majority of these children contracted the virus by perinatal transmission. 
An underrepresented story of the Nigerian HIV/AIDS epidemic is the issue of 
AIDS orphans. At the end of 2001, an estimated 1 million children under the age of 15 
were orphaned as a direct consequence of the epidemic. This number is projected to 
increase to 2.5 million by 2010. (14) Although it is concerning that Nigeria does not 
possess the systems and structures necessary to care for healthy orphans, the burden of 
caring for HIV-positive orphaned children will be much greater. These projections 
highlight the necessity of comprehensive Prevention of Mother-to-Child Transmission 
(PMTCT) programs to reduce the number of HIV-positive orphans who contract the virus 
through perinatal transmission. 
C. Government Efforts and Policies 
During the beginning stages of the epidemic in Nigeria in the early 1990’s, the 
government did very little. Prior to this, almost all of the efforts against HIV were 
conducted by the numerous Non-Governmental Organizations (NGOs) throughout the 
country. However, with the advent of civilian rule in 1999 when Mr Olusegun Obasanjo 
became president of Nigeria, the government’s response to the HIV/AIDS epidemic 
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increased significantly. The government decided to make HIV/AIDS a national priority 
and consequently established a national body known as NACA (Nigerian Action 
Committee Against AIDS) to formulate and implement policy to address the HIV/AIDS 
situation. In 2001, NACA developed a 3-year strategic plan, the HIV/AIDS Emergency 
Action Plan (HEAP), to address the HIV/AIDS situation. One of the sub-strategies 
identified in the HEAP Plan was to implement an extensive PMTCT program to address 
the growing number of HIV-positive children that were contracting the virus via perinatal 
transmission. At the time, the only option available to HIV infected pregnant women was 
termination of pregnancy. Most women were unaware of their status and so did not do 
anything to prevent vertical transmission (15). 
I). Prevention of Maternal to Child Transmission (PMTCT) 
Perinatal HIV transmission without antiretroviral drug intervention is estimated to range 
from 14 to 48% (16). In 1994, Pediatric AIDS Clinical Trial Group protocol 076 
(PACTG 076) showed that administration of zidovudine to HIV-infected women during 
pregnancy, labor and to the newborn for at least 6 weeks after delivery reduced perinatal 
transmission by almost two-thirds (from 25.5% to 8.3%) among women who did not 
breastfeed (17). Subsequently, the HIVNET-012 trial showed that peripartum nevirapine 
was a more cost-effective regimen for PMTCT in resource-poor countries. This study 
showed that a combination of nevirapine and earlier weaning would decrease perinatal 
transmission to approximately 15% at 5 years (18). 

9 
The combination of HIV screening, counseling, and antiretroviral drug 
administration has dramatically reduced mother-to-child transmission of HIV in western 
countries (19,20). In the developing world, however, the uptake of PMTCT programs has 
been inadequate due to deficiencies in staff and resources, logistical problems such as 
high import duties on the drugs, and lack of funds. In July 2000, the German based 
company Boehringer Ingelheim pledged to donate the drug nevirapine to all 
governments, individuals, NGOs or private organizations in World Bank classified “least- 
developed” countries which agreed to institute a PMTCT program. Over the first couple 
years, there was a slow initial uptake by the countries, which was attributed to problems 
with logistics and staff supply. However, as of August 2003, 44 countries from Africa, 
Eastern Europe, Asia, and the Caribbean had taken up Boehringer Ingelheim’s donation. 
Nigeria became a recipient of this drug donation program in November 2001. 
E. Nigeria’s National PMTCT Program 
As pail of the Nigerian Emergency Action Plan, a national policy was formulated with 
the objective of implementing a comprehensive PMTCT system of antenatal HIV 
counseling and testing and antiretroviral treatment. Although the PMTCT program was 
scheduled to be launched in 2001, it was delayed because of financial and ethical 
obstacles. The PMTCT program was finally initiated at 8 pilot centers in June 2002. The 
pilot centers are all located at teaching hospitals throughout the country. These include: 
(1) Ahmadu Bello University Teaching Hospital Zaria, Kaduna; (2) University of 
Maiduguri, Borno; (3) Lagos University Teaching Hospital, Lagos; (4) University of 
Nigeria Teaching Hospital, Enugu; (5) National Hospital, Abuja; (6) Jos University 
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Teaching Hospital, Jos; (7) University of Port Harcourt Teaching Hospital, Port- 
Harcourt; and (8) University College Hospital Ibadan, Oyo. (Figure 2) 
FIGURE 2: Location of Pilot Centers (Reproduced from www.greenwichmeantime.com) 
The program aims to treat pregnant mothers using the HIVNET 012 regimen (one dose of 
oral nevirapine 200 mg at the onset of labor followed by a dose of 2 mg/kg orally to the 
child within 3 days of birth). In addition, all mothers (and HIV-positive children) are 
eligible to receive free antiretroviral treatment after delivery. The stated goal is to treat 
5,000 HIV-positive pregnant women by 2004. As of 2002, only 141 HIV-positive women 
had been enrolled in the national PMTCT program. This represents only 1 of every 2,000 
HIV-positive pregnant women. In an attempt to reach more HIV-positive pregnant 
women, other organizations such as Family Health International, an international NGO, 
have plans to launch additional PMTCT sites in different Nigerian states. 

F. Challenges with PMTCT Programs 
Despite the relative efficiency of antiretroviral drugs in reducing perinatal transmission, 
complete prevention of MTCT transmission is predicated on a number of external factors 
such as a system of antenatal testing, continuous drug availability during labor and in the 
immediate postpartum period, and the awareness and willingness of healthcare providers 
to recruit or diagnose HIV-positive women. This action requires that healthcare providers 
not only provide counseling and testing consistently, but also maintain the appropriate 
knowledge regarding perinatal transmission and chemoprophylaxis in HIV-positive 
pregnant women (21). It is not surprising, therefore, that studies have shown that the 
attitudes, values, and knowledge of health care providers can play a huge part in the 
health outcomes of their patients partly due to the way in which they present and discuss 
issues with patients. (22) 
G. Knowledge, Attitudes and Practices of healthcare providers towards people living 
with HIV/AIDS. 
Several studies have been done on a global level to document the knowledge, attitudes 
and practices of healthcare providers towards people living with HIV/AIDS. In the early 
1990’s, there was a low level of knowledge and widespread negative attitudes among 
majority of healthcare providers towards such patients. Since then, however, there has 
been a trend towards increased basic knowledge levels and more positive attitudes 
towards people living with HIV/AIDS. This has been attributed in large part to extensive 
training of healthcare providers. However, there has been little data collected on the 
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knowledge, attitudes, and practices of providers regarding the PMTCT services. This 
dearth of information provided the impetus for the implementation of our study. More 
recently, a large-scale study to examine the role of attitudes and practices of healthcare 
providers on PMTCT programs was initiated by the Quality Assurance Project in 
Rwanda. 
Healthcare providers are essential players in educating society about HIV/AIDS 
prevention and transmission. In addition, these providers play a pivotal role in the care 
and treatment of people living with HIV/AIDS in Nigeria. Healthcare providers are 
subject to a higher risk of infection when caring for HIV infected or AIDS patients. 
Consequently, fears of infection and general perceptions may serve as a barrier to the 
provision of care to such patients and their families. Oftentimes, health care providers 
may deny people living with HIV/AIDS access to healthcare because of the perception 
that they have HIV/AIDS. A recent study conducted in Lagos, Nigeria demonstrated 
that only 18% of healthcare providers would visit a person living with HIV/AIDS while 
only 53% would be willing to work in the same office as such a person. These numbers 
are particularly alarming when interpreted in the context of a nationally sanctioned 
PMTCT program. To make this type of a program successful, healthcare providers will 
undoubtedly have to play a major role in encouraging HIV-positive pregnant women to 
take nevirapine to decrease the risk of HIV transmission to their children. To increase the 
enrollment of pregnant women into the voluntary counseling and testing program, it is 
imperative that healthcare providers are informed and sensitized to this particular 
population. Studies are currently being conducted by the Quality Assurance Project to 
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examine the impact of HIV/AIDS stigma among healthcare providers on the quality of 
care provided in PMTCT services. These studies are being carried out in Rwanda, 
Tanzania, and Haiti to assess HIV knowledge, attitudes, and practices of health providers 
as a first step towards designing interventions to reduce stigma. 
In order to improve the health status of Nigerian HIV-positive pregnant women and to 
decrease perinatal transmission of HIV infection, the relationship between knowledge of 
PMTCT and attitudes and practices concerning prenatal screening and antiretroviral drug 
administration should be explored. There are currently no published studies on the 
knowledge and attitudes of Nigerian health care providers towards pregnant women with 
HIV/AIDS. Our study aims to evaluate the knowledge and attitudes of Nigerian health 
care providers towards prenatal screening and PMTCT in Nigerian pregnant women. 
STATEMENT OF PURPOSE AND HYPOTHESIS 
The purpose of this study was to assess the knowledge, attitudes, and practices of 
healthcare providers towards antenatal HIV screening and the prevention of mother-to- 
child transmission of HIV in Nigerian pregnant women. We surveyed physicians and 
nurses at three teaching hospitals and four private hospitals in Nigeria on their views and 
practices regarding HIV testing in pregnant women and the use of antiretroviral therapy 
to prevent perinatal transmission. The teaching hospitals comprise two of the eight 
designated pilot centers for the national PMTCT program. 
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We hypothesized that Nigerian healthcare providers’ level of knowledge of mother- 
to-child transmission would be low and their attitudes towards antenatal HIV screening 
would hinder the success of the nationally sanctioned PMTCT program. The aims of the 
study were: 
(1) To define the providers attitudes towards pregnant women with HIV, 
(2) To document their knowledge of mother-to-child transmission of the HIV virus, and 
(3) To assess the impact of their knowledge, attitudes, and practices on the feasibility of 
the nationally sanctioned PMTCT program. 
METHODS 
We performed an anonymous cross-sectional survey of healthcare providers at three 
major teaching hospitals and four private health care facilities in Nigeria. Institutional 
Review Board approval was obtained from the Yale University School of Medicine. The 
teaching hospitals were: Gwawaladja Hospital in Abuja, the Federal Capital Territory and 
Lagos University Teaching Hospital in Lagos, and the University of Nigeria Teaching 
Hospital in Enugu. The private hospitals were located in Lagos: Schubbs Dental Clinic, 
Child Care Pediatrics, International Medical Group (IMG), and Life Support Clinic . We 
chose to survey an array of healthcare providers including both nurses and physicians, 
because this group of professionals is responsible for counseling pregnant women before 
and after HIV testing, for performing the HIV test, and for administering the medication. 
The physicians surveyed were family practitioners and obstetrician-gynecologists. This 
group of healthcare providers caters to most pregnant women who seek antenatal care in 
urban Nigeria. They are in a unique position to reduce HIV perinatal transmission by 

15 
screening pregnant women, identifying those who are HIV-positive, and offering 
antiretroviral therapy to them in order to decrease the incidence of pediatric HIV/AIDS 
by mother-to-child transmission. 
A total of 150 self-administered 12-question surveys were fielded at the 7 different 
health care facilities and there was a response rate of 57.3% (86 surveys were returned). 
Survey questions included provider knowledge about facility testing capabilities and 
utility of antiretroviral therapy in PMTCT as well as provider attitudes and behavior 
regarding HIV screening in pregnant women. The surveys were fielded from June to July 
2000. 
There were 3 or less respondents at three of the hospitals surveyed, including 
Scrubbs Dental Clinic, IMG, and ChildCare Pediatrics. As such, the data from these 
respondents (9 in total) were removed from the analysis. In addition, three laboratory 
technologists erroneously filled out the survey and their data too was excluded from the 
analysis. This gave an overall response rate of 51.3% (77 out of 150 respondents). Chi- 
square tests for proportions were used to evaluate significance of difference between the 
categorical variables. A significance level of 0.05 was used for the data analysis. 

RESULTS 
Physicians Knowledge 
Questions Yes 
Number (%) 
No 
Number {%) 
No Answer 
Number (%) 
1. HIV Testing is available in their work area 53/55 (96.3) 2/55 (3.6) 
2. Results of HIV testing are available in 24 hours 29/55 (52.7) 26/55 (47.2) 
3. Results of HIV testing are available in 6 hours. 14/55 (25.4) 40/55 (72.7) 1/55 (1.8) 
4. HIV medications can be used safely during pregnancy 35/55 (63.6) 10/55 (18.1)' 10/55 (18.1) 
5. HIV medications can be used safely during labor 37/55 (67.2) 7/55 (12.7) 11/55 (20.0) 
6. Treatment with ATT during labor reduces maternal to 
child transmission of HIV. 
36/55 (65.4) 6/55 (10.9) 13/55 (23.6) 
7. HIV medications given to pregnant women cause fetus 
harm 
12/55 (21.8) 29/55 (52.7) 14/55 (25.4) 
Physician's knowledge of the availability of HIV testing facilities at their respective 
hospitals was high, with 96.4% of the physicians aware that testing was available at their 
centers. However, their knowledge of the timing of results was low. Discussion with the 
clinical laboratories at each of the centers confirmed that, at all the centers, HIV test 
results were available an average of 72 hours later. There were no centers where HIV test 
results were available in 24 hours or 6 hours. Only 47.3% (26/55) of physicians were 
aware that test results were not available in 24 hours, while 72.7% (40/55) of physicians 
were aware that rapid testing was not available (these results were not available in 6 
hours). 63.7% (35/55) knew that HIV medications could be used safely during 
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pregnancy, while 67.3% (37/55) knew that HIV medications could be used safely during 
labor. Overall, 65.5% (36/55) knew that AZT could be used to reduce maternal to child 
transmission of HIV, while only 52.7% (29/55) believed that HIV medications do not 
cause harm to the fetus. 
Physicians Attitudes 
Questions Yes No No Answer 
Number (%) Number (%) Number (%) 
1. Pregnant Women should be screened for HIV during pregnancy 49/55 (89.1) 10.91% 
2. Pregnant women should be screened for HIV during labor if their 39/55 (70.9) 14/55 (25.5) 2/55 (3.6) 
status is unknown or was not tested during pregnancy 
3. Important to know HIV status of women during pregnancy 50/55 (90.9) 5/55 (9.1%) 
In terms of physician’s attitudes, 89.1% (49/55) felt that women should be screened for 
HIV during pregnancy while 70.9% (39/55) believed that women should be screened for 
HIV during labor if they had not been tested during pregnancy. In addition, 90.9% 
(50/55) felt that it was important to know the HIV status of women during pregnancy. 
Physician Practices 
Questions Yes No No Answer 
Number (%) Number (%) Number (%) 
I. Most women they take care of are HIV-positive. 1/55 (1.8) 53/55 (96.4) 1/55 (1.8) 
2. They routinely inquire about maternal HIV status at labor onset 21/55 (38.2) 29/55 (52.7) 5/55 (3.6) 
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Most of the physicians surveyed said that they do not take care of HIV-positive women. 
Most respondents said they do not take care of HIV-positive women (96.4%) while one 
respondent said she did and one respondent gave no answer. 
Nurses Knowledge 
Questions Yes No No Answer 
Number (%) Number (%) Number (%) 
/. HIV Testing is available in tlieir work area 100% 
- 
2. Results of HIV testing are available in 24 hours 14/15 (93.3) 1/15 (6.7) - 
3. Results of HIV testing are available in 6 hours. 8/15 (53.3) 7/15 (46.7) ~ 
4.HIV medications can be used safely during pregnancy 4/15 (26.7) 5/15 (33.3) 6/15 (40) 
5. HIV medications can be used safely during labor 4/15 (26.7) 5/15 (33.3) 6/15 (40) 
6. Treatment with AZT during labor reduces maternal to child 7/15 (46.7) 3/15 (20) 5/15 (33.3) 
transmission of HIV. 
7. HIV medications given to pregnant women cause fetus harm 5/15 (33.3) 4/15 (26.7) 6/15 (40) 
Unlike physicians, all nurses knew that HIV testing is available in their work area. Only 
6.7% (1/15) knew that results of HIV testing were not available within 24 hours while 
only 46.7% (7/15) knew that results of HIV testing were not available within 6 hours. 
Only 26.7% (4/15) of nurse respondents knew that HIV medications might be used safely 
during pregnancy and during labor. In addition, only 46.7% (7/15) of respondents knew 
that treatment with AZT during pregnancy reduces MTCT. Lastly, one quarter (26.7%) of 
nurses believed that HIV medications causes harm to the fetus. 

19 
Nurses Attitudes 
Questions Yes No No Answer 
Number (%) Number (%) Number (%) 
1. Pregnant Women should be screened for HIV during pregnancy 15/15 (100) 
2. Pregnant women should be screened for HIV during labor if their 14/15 (93.3) 1/15 (6.7) 
- 
status is unknown or was not tested during pregnancy 
3. Important to know HIV status of women during pregnancy 15/15 (100) " - 
Unlike physicians, all nurse respondents felt that pregnant women should be screened for 
HIV during pregnancy. In addition, 93.3% (14/15) of nurses felt that women should be 
screened for HIV during labor if they were not tested during pregnancy. All nurses felt 
that it was important to know HIV status of women during pregnancy. 
Nurses Practices 
Questions Yes No No Answer 
Number (%) Number t%) Number (%) 
1. Most women they take care of are HIV-positive. 1/15 (6.7) 14/15 (93.3) 
- 
2. They routinely inquire about maternal HIV status at labor onset 9/15 (60) 4/15 (26.7) 2/15 (13.3) 
Overall, a larger proportion of nurses appeared to believe that the women they served 
were HIV-positive and were more likely to inquire about HIV status at labor onset than 
physicians. 
There were significant differences between the physicians and nurses regarding their 
knowledge of the HIV testing capabilities of their facilities (p=0.004). There was also a 
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significant difference between the proportion of physicians and nurses who knew that 
antiretroviral medications could be used safely during pregnancy and during labor. 
(p^O.Ol; p=0.004 respectively). The differences between physicians and nurses’ level of 
knowledge regarding the other areas of mother-to-child transmission were not statistically 
significant. (Figure 3) 
100.00% 
90.00% 
80.00% 
70.00% 
60.00% 
50.00% 
40.00% 
30.00% 
20.00% 
10.00% 
0.00% 
HIV testing available in avail in 6h used safely used safely reduces cause fetus 
Avail Of Results Results HIV meds HIV meds Tx with AZT HIV meds 
24h during labor during MTCT harm 
pregnancy 
□ Physicians 
■ Nurses 
FIGURE 3: Comparison of physicians and nurses level of knowledge. 
Across the four hospitals surveyed, there were differences in levels of knowledge, 
attitudes, and practices between healthcare providers: 
University Teaching Hospital (l NTH) 
Providers ’ Knowledge 
At UNTH, 92.6% (25/27) of healthcare providers knew that HIV testing is available in 
their work area. 55.6% (15/27) of respondents knew that results of HIV testing were not 
available within 24 hours while only 77.8% (21/27) knew that results of HIV testing were 
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not available within 6 hours. Only 55.6% (15/27) of respondents knew that HIV 
medications may be used safely during pregnancy and 59.3% (16/27) of respondents 
knew that these medications could be used safely during labor. In addition. 74.1% (20/27) 
of respondents knew that treatment with AZT during pregnancy reduces mother-to-child 
transmission. Lastly, 48.2% (13/27) believed that HIV medications cause fetuses harm. 
Providers Attitudes 
Twenty-five respondents (92.6%) felt that pregnant women should be screened for HIV 
during pregnancy. However, 74.1% (20/27) of respondents felt that women should be 
screened for HIV during labor if they were not tested during pregnancy. Majority of 
respondents (92.6%) felt that it was important to know HIV status of women during 
pregnancy. 
Providers Practices 
Less than half of respondents (40.7%) said that they routinely inquire about the HIV 
status of pregnant women. Only one respondent stated that most of the women he took 
care of are HIV-positive. Although data does not exist for the prevalence of HIV-positive 
patients who attend the different healthcare facilities, there are numbers for the 
prevalence rates at antenatal centers in different regions. In Enugu state where UNTH is 
located, the HIV prevalence rate in 1999 was estimated to be 4.7% (23). 
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Lagos University Teaching Hospital (LUTH) 
Providers ’ Knowledge 
At LUTH, out of 13 respondents, 100% of healthcare providers knew that HIV testing is 
available in their work area. Yet, only 33.8% (4/13) of respondents knew that results of 
HIV testing were not available within 24 hours while 69.2% (9/13) knew that results of 
HIV testing were not available within 6 hours. Only 53.9% (7/13) of respondents knew 
that HIV medications may be used safely during pregnancy and 46.2% (6/13) of 
respondents knew that these medications could be used safely during labor. In addition, 
46.2% (6/13) of respondents knew that treatment with AZT during pregnancy reduces 
mother-to-child transmission. Lastly, 46.2% (6/13) knew that HIV medications do not 
cause fetuses harm. 
Providers Attitudes 
Nine respondents (69.2%) felt that pregnant women should be screened for HIV during 
pregnancy. However, only 7 respondents (53.9%) felt that women should be screened for 
HIV during labor if they were not tested during pregnancy. Ten respondents (76.9%) felt 
that it was important to know HIV status of women during pregnancy. 
Providers Practices 
All respondents denied that the majority of patients they take care of are HIV-positive yet 
only 38.5% (5/13) of respondents said that they routinely inquire about the HIV status of 
pregnant women. The HIV prevalence rate in Lagos state was estimated to be 6.7% in 
1999 (24). 
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Gwawaladja Teaching Hospital 
Providers ’ Knowledge 
At Gwaradja, out of 20 respondents, 100% of healthcare providers knew that HIV testing 
is available in their work area. Yet, only 43.5% (9/20) of respondents knew that results of 
HIV testing were not available within 24 hours while 87% (17/20) knew that results of 
HIV testing were not available within 6 hours. Approximately 73.9% (15/20) of 
respondents knew that HIV medications might be used safely during pregnancy and 
during labor. In addition, 73.9% (15/20) of respondents knew that treatment with AZT 
during pregnancy reduces mother-to-child transmission. Lastly, 34.8% (7/20) knew that 
HIV medications do not harm the fetus. 
Providers Attitudes 
Most respondents (95.65%) felt that pregnant women should be screened for HIV during 
pregnancy. However, fewer respondents (16/20) felt that women should be screened for 
HIV during labor if they were not tested during pregnancy. The majority of respondents 
(19/20) felt that it was important to know HIV status of women during pregnancy. 
Providers Practices 
Only 1 respondent claimed to serve predominantly HIV-positive patients while a little 
more than half of respondents (52.2%) routinely inquire about the HIV status of their 
patients. The HIV prevalence rate in Abuja was determined to be 7.2% in 1999. (25) 
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Life Support Center 
Providers ’ Knowledge 
At Life Support Center, out of 13 respondents, 100% of healthcare providers knew that 
HIV testing is available in their work area. Yet, no respondents knew that results of HIV 
testing were not available within 24 hours and none of the respondents knew that results 
of HIV testing were not available within 6 hours. Only 23.1% (3/13) of respondents knew 
that HIV medications might be used safely during pregnancy during labor. In addition, 
only 30.8% (4/13) of respondents knew that treatment with AZT during pregnancy 
reduces mother-to-child transmission. Lastly, only 15.4 % (2/13) knew that HIV 
medications do not harm the fetus. 
Providers Attitudes 
All respondents felt that pregnant women should be screened for HIV during pregnancy. 
Most respondents (92.3%) felt that women should be screened for HIV during labor if 
they were not tested during pregnancy. All respondents felt that it was important to know 
HIV status of women during pregnancy. 
Providers Practices 
All respondents denied that the majority of patients they take care of are HIV-positive yet 
only 38.5% (8/13) routinely inquire about the HIV status of their patients. The 
prevalence rate of HIV in Lagos state (where Life Support is located) is 6.7%. (26) 
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DISCUSSION 
The 2002 UNAIDS Update stressed that, given its large population and an HIV 
seroprevalence rate of 5.8%, Nigeria is one of four countries in the world with the largest 
number of people living with HIV/AIDS (27). Indeed, Nigeria’s 3.5 to 4 million cases of 
HIV account for almost one-tenth of the HIV/AIDS cases worldwide. Furthermore, the 
federal government projects that, by the end of 2004, there will be an additional 500,000 
new cases of HIV with 350,000 cases occurring in mainly reproductive age women. 
When these numbers are interpreted within the context of maternal-to-child transmission, 
they indicate that - in the absence of medical and social intervention - the number of 
children born with HIV is likely to increase substantially. The provision of antiretroviral 
prophylaxis to HIV-positive pregnant woman is one of the critical elements to mitigating 
this aspect of the epidemic and reducing the number of children born with HIV. The 
recent efforts by the national government, the private sector, and the civil society to 
institute PMTCT programs throughout Nigeria are undoubtedly a major step to reduce the 
number of perinatally transmitted HIV cases. However, if healthcare providers are not 
well informed about basic HIV/AIDS knowledge and if their attitudes about the viability 
of screening HIV-positive pregnant women and offering antiretroviral therapy to such 
women to prevent perinatal transmission remain negative, then the utility of such 
programs will certainly be impaired. 
Our survey indicates that two-thirds (65.5%) of all physician respondents were 
knowledgeable about the utility of antiretroviral drugs in preventing the transmission of 
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HIV from mother to child. Furthermore, only half (52.7%) of all physician respondents 
were aware that such drugs would not cause the fetus harm. It is alarming that at one of 
the major PMTCT centers and one of the premier teaching centers in the country, LUTH, 
less than half of both physician and nurse respondents were aware that treatment of the 
mother with AZT reduces mother-to-child transmission of HIV and that HIV medications 
can be used safely during labor. These numbers were only slightly higher at UNTH, 
another top teaching hospital and national PMTCT center. At the private center. Life 
Support, the level of knowledge was very low. Nigerian teaching hospitals usually are 
more up to date with new research findings; however, physicians who practice at such 
hospitals usually supplement their earnings by practicing at private hospitals. The 
expectation is that this dual-job lifestyle of academic physicians benefits the private 
hospitals through the provision of current medical information and research to these 
hospitals. The low levels of knowledge at the private medical center suggest that more 
center-specific training is needed for healthcare providers. This lack of knowledge among 
providers may prove to be a major barrier in the identification of pregnant women who 
are HIV-positive and could facilitate the growing number of HIV-infected children being 
born each day. 
Nurses also appear to have a very low level of knowledge, which has been replicated in 
numerous studies (28). However, a larger proportion of the nurses appeared to have 
attitudes and behavior more conductive to identifying HIV-positive women. The 
majority believed that it is important to know the HIV status of women and report that 
they routinely inquire about the status of the women they see. As can be seen in Figure 3, 
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despite the larger proportion of positive attitudes and practices among nurses, physicians 
had higher levels of knowledge than the nurses. 
The significant differences in the level of knowledge between physicians and nurses 
highlights the need for programs designed for both types of healthcare providers. 
Although the baseline level of knowledge for either type of healthcare provider is 
unacceptable, the fact that nurses have lower levels of knowledge than physicians should 
be addressed by the creation of education and training programs specific for them. 
Given that healthcare providers are in a unique position to identify pregnant women 
with HIV and to consequently offer a means for them to reduce the likelihood of 
transmitting the virus to their newborns, it is concerning that they have such a low level 
of knowledge. Since the study was done before the implementation of the national policy 
on the establishment of 8 PMTCT centers, it is possible that subsequent training has led 
to improvements in the AIDS-related knowledge, attitudes, and practices among 
healthcare providers in Nigeria. However, the National Action Committee on AIDS 
(NACA) did state that they have had difficulty in the establishment of these centers, and 
cited a lack of adequate training as one of the major barriers to the institution of the 
centers. 
It is imperative that all healthcare providers who will influence a pregnant woman’s 
decision to be screened for HIV and to receive antiretroviral prophylaxis should receive 
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comprehensive training on basic AIDS-related information and on HIV/AIDS disease 
management. 
Prior to the institution of the PMTCT programs, healthcare providers may have 
been uncomfortable with inquiring about the status of their patients because they felt that 
there were no treatment options available for them. Although exclusive breastfeeding and 
elective cesarean procedures are also effective in reducing perinatal transmission, these 
options are not readily available to women in resource-poor countries. Exclusive formula¬ 
feeding requires continuous access to and availability of clean water, a rarity in many 
developing countries. Women in these countries often cannot afford to purchase formula, 
thus breast milk is usually the only available source of nutrition for the child. An 
exclusively formula-fed child in a region without access to safe water is at increased risk 
of malnutrition and diarrhea. In addition, stigmatization of women who exclusively 
formula-feed in developing countries is often a deterrent to women who consider 
discontinuing breast-feeding. Elective caesarean procedures are not feasible for the 
general population in resource-poor regions given that most women deliver at home and 
not in the hospital. For the women who do deliver in the hospital, c-sections are an added 
expense that they often cannot afford. In addition, few hospitals in Nigeria have adequate 
staffing, surgical supplies, drugs, and blood products that would be necessary. As such, 
the provision of antiretroviral drugs to mothers and infants is the most feasible 
intervention to significantly reduce perinatal transmission in Nigeria. 
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Since many providers were unaware that antiretroviral drugs can be used to reduce 
the risk of perinatal transmission, they likely believed there was little utility in asking 
about the status of their patients. This is the reason often given when healthcare providers 
are asked why they do not inquire about the HIV status of their patients. Given that 
healthcare providers are often considered to be the largest perpetrators of stigma towards 
people living with AIDS, it is possible that the providers did not want to know the HIV 
status of their patients because of their own stigmatization of persons living with 
HIV/AIDS. 
At the private healthcare facility. Life Support Center, most respondents felt that it 
was important to know the HIV status of pregnant women. This was particularly 
interesting since a low number of these same respondents (25%) believed that treatment 
with AZT could reduce the risk of delivering an HIV-positive child. 
Limitations of our study include the relatively low response rate, which may impede 
our ability to generalize these results to all healthcare providers in Nigeria. In addition, 
the survey questionnaire did not elicit the demographic or specialty details of the 
physicians. The lack of HIV-prevalence specific data at each health care center made it 
difficult to compare the actual demographics of the patient populations with the self- 
reports of the healthcare providers. In addition, we did not investigate the reasons for the 
negative attitudes on the part of the healthcare providers. Despite these limitations, the 
survey gives credence to the need for comprehensive and continuous training of 
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healthcare providers regarding their knowledge and attitudes toward HIV screening and 
antiretroviral treatment of pregnant women. 
The low knowledge levels and negative attitudes and practices of healthcare 
providers towards pregnant women with HIV are major barriers to the success of the 
nationally sanctioned PMTCT programs in Nigeria. Nigeria’s HIV epidemic is projected 
to worsen significantly in the next few years. The burden of the epidemic can be 
mitigated, at least in part, by reducing the mother-to-child transmission of HIV through 
the identification of HIV-positive pregnant women and the use of antiretroviral 
prophylaxis to them during labor. Healthcare providers in Nigeria must receive adequate 
and continuous comprehensive AIDS-related training in order for these PMTCT 
programs to be successful. 
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ADDENDUM 
Questionnaire for Health Care Providers on HIV Testing 
Hospital_ 
Occupation_ 
YES NO 
1. HIV testing is available in my work area. Y N 
2. Results of HIV testing are available within 24 hours. Y N 
3. Results of HIV testing are available within 6 hours. Y N 
4. Most women that 1 take care of are HIV positive. Y N 
5. Pregnant women should have HIV testing during their pregnancy. Y N 
6. If a pregnant woman has not had HIV testing during the pregnancy, Y N 
she should have testing when she comes into labor. 
7. It is important to know HIV status of women during their pregnancy. Y N 
8. I routinely inquire about maternal HIV status at the onset of labor. Y N 
9. HIV medications can be used safely by a woman during pregnancy. Y N 
10. HIV medications can be used safely during labor. Y N 
11. Treatment for HIV during labor with AZT reduces the transmission of Y N 
the HIV virus from mother to child. 
12. HIV medications given to women when they are pregnant cause harm Y N 
to the fetus. 
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